HIRSCHMAN ORIN 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-27 08:08 am Sale |
2022-10-26 | 13G | TransCode Therapeutics, Inc. RNAZ |
HIRSCHMAN ORIN | 0 0.000% |
-49 (Position Closed) |
Filing |
| 2022-02-11 3:06 pm Purchase |
2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
HIRSCHMAN ORIN | 49 9.900% |
1 (+1.46%) |
Filing |
| 2021-07-20 5:55 pm Purchase |
2021-07-09 | 13G | TransCode Therapeutics, Inc. RNAZ |
HIRSCHMAN ORIN | 48 9.900% |
48 (New Position) |
Filing |